Clinical outcomes and variability based on baseline cytogenetic risk of patients with MDS treated with hypomethylating agents: An analysis from the International Consortium for MDS (icMDS) validate database Meeting Abstract


Authors: Getz, T. M.; Kewan, T.; Bewersdorf, J. P.; Stempel, J. M.; Lanino, L.; Wei, W.; Ali, N. H. A.; Dezern, A. E.; Sekeres, M. A.; Uy, G. L.; Carraway, H. E.; Desai, P.; Stein, E. M.; Brunner, A. M.; McMahon, C. M.; Shallis, R. M.; Griffiths, E. A.; Zeidner, J. F.; Savona, M. R.; Ball, S.; Chandhok, N. S.; Logothetis, C.; Bidikian, A.; Roboz, G. J.; Rolles, B.; Wang, E. S.; Harris, A. C.; Amaya, M. L.; Hawkins, H.; Grenet, J.; Xie, Z. E.; Madanat, Y. F.; Abaza, Y.; Badar, T.; Haferlach, T.; Maciejewski, J.; Sallman, D.; Enjeti, A. K.; Al-Rabi, K.; Halahleh, K.; Hiwase, D.; Diez-Campelo, M.; Valcarcel, D.; Pleyer, L.; Kotsianidis, L.; Pappa, V.; Santini, V.; Consagra, A.; Al-Kali, A.; Ogawa, S.; Nannya, Y.; Stahl, M.; Porta, M. G. D.; Komrokji, R. S.; Zeidan, A. M.
Abstract Title: Clinical outcomes and variability based on baseline cytogenetic risk of patients with MDS treated with hypomethylating agents: An analysis from the International Consortium for MDS (icMDS) validate database
Meeting Title: 66th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 144
Issue: Suppl. 1
Meeting Dates: 2024 Dec 7-10
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2024-11-05
Start Page: 3219
Language: English
ACCESSION: WOS:001420868700001
DOI: 10.1182/blood-2024-202075
PROVIDER: wos
Notes: Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eytan Moshe Stein
    364 Stein